A detailed history of Thornburg Investment Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Thornburg Investment Management Inc holds 812,375 shares of ABBV stock, worth $146 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares
812,375
Previous 807,598 0.59%
Holding current value
$146 Million
Previous $139 Million 15.82%
% of portfolio
2.24%
Previous 2.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $782,663 - $952,199
4,777 Added 0.59%
812,375 $160 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $31.5 Million - $35.9 Million
-197,107 Reduced 19.62%
807,598 $147 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $265,020 - $329,800
2,000 Added 0.2%
1,004,705 $135 Million
Q1 2023

May 09, 2023

SELL
$144.61 - $166.54 $11.1 Million - $12.8 Million
-76,879 Reduced 7.12%
1,002,705 $160 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $42.5 Million - $50.9 Million
-307,163 Reduced 22.15%
1,079,584 $175 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $167 Million - $191 Million
-1,243,301 Reduced 47.27%
1,386,747 $186 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $16.9 Million - $21.5 Million
-122,659 Reduced 4.46%
2,630,048 $403 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $95.6 Million - $119 Million
-724,519 Reduced 20.84%
2,752,707 $446 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $6.74 Million - $8.52 Million
-62,705 Reduced 1.77%
3,477,226 $471 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $12.4 Million - $14.1 Million
116,341 Added 3.4%
3,539,931 $382 Million
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $3.28 Million - $3.65 Million
-31,178 Reduced 0.9%
3,423,590 $386 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $193,244 - $212,739
1,889 Added 0.05%
3,454,768 $374 Million
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $20.6 Million - $27.8 Million
-255,389 Reduced 6.89%
3,452,879 $370 Million
Q3 2020

Nov 05, 2020

SELL
$85.91 - $100.83 $2.37 Million - $2.79 Million
-27,637 Reduced 0.74%
3,708,268 $325 Million
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $21.3 Million - $28.5 Million
289,896 Added 8.41%
3,735,905 $367 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $45.5 Million - $69 Million
705,697 Added 25.75%
3,446,009 $263 Million
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $251,373 - $314,521
3,485 Added 0.13%
2,740,312 $243 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $114 Million - $136 Million
1,802,197 Added 192.82%
2,736,827 $207 Million
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $61.4 Million - $78.5 Million
934,630 New
934,630 $68 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Thornburg Investment Management Inc Portfolio

Follow Thornburg Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Thornburg Investment Management Inc with notifications on news.